|CompTox Dashboard (EPA)|
|Chemical and physical data|
|Molar mass||183.68 g/mol g·mol−1|
|3D model (JSmol)|
|(what is this?)|
Clortermine (Voranil) was developed by Ciba in the 1960s and is an anorectic drug of the amphetamine class. It is the 2-chloro analogue of the better known appetite suppressant phentermine, and is the 2-chloro positional isomer of chlorphentermine. Clortermine produces very low rates of self-administration in animals similarly to chlorphentermine, and as a result it likely does not act on dopamine. Instead, it may act as a serotonin and/or norepinephrine releasing agent.
- US patent 3415937, "The Suppression of Appetite with 1-(o-Chlorophenyl)-2-Methyl-2-Propylamine"
- Triggle, D. J. (1996). Dictionary of Pharmacological Agents. Boca Raton: Chapman & Hall / CRC. ISBN 0-412-46630-9.
- Sannerud, C. A.; Brady, J. V.; Griffiths, R. R. (1989). "Self-Injection in Baboons of Amphetamines and Related Designer Drugs". NIDA Research Monograph. 94: 30–42. PMID 2514366.
|This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.|